首页> 外文期刊>BMC Nephrology >Rationale and design for SHAREHD: a quality improvement collaborative to scale up Shared Haemodialysis Care for patients on centre based haemodialysis
【24h】

Rationale and design for SHAREHD: a quality improvement collaborative to scale up Shared Haemodialysis Care for patients on centre based haemodialysis

机译:ShareHD的理由和设计:对中心血液透析患者扩大共享血液透析护理的质量改进

获取原文
           

摘要

The study objective is to assess the effectiveness and economic impact of a structured programme to support patient involvement in centre-based haemodialysis and to understand what works for whom in what circumstances and why. It implements a program of Shared Haemodialysis Care (SHC) that aims to improve experience and outcomes for those who are treated with centre-based haemodialysis, and give more patients the confidence to dialyse independently both at centres and at home. The 24 month mixed methods cohort evaluation of 600 prevalent centre based HD patients is nested within a 30 month quality improvement program that aims to scale up SHC at 12 dialysis centres across England. SHC describes an intervention where patients who receive centre-based haemodialysis are given the opportunity to learn, engage with and undertake tasks associated with their treatment. Following a 6-month set up period, a phased implementation programme is initiated across 12 dialysis units using a randomised stepped wedge design with 6 centres participating in each of 2 steps, each lasting 6 months. The intervention utilises quality improvement methodologies involving rapid tests of change to determine the most appropriate mechanisms for implementation in the context of a learning collaborative. Running parallel with the stepped wedge intervention is a mixed methods cohort evaluation that employs patient questionnaires and interviews, and will link with routinely collected data at the end of the study period. The primary outcome measure is the number of patients performing at least 5 dialysis-related tasks collected using 3 monthly questionnaires. Secondary outcomes measures include: the number of people choosing to perform home haemodialysis or dialyse independently in-centre by the end of the study period; end-user recommendation; home dialysis establishment delay; staff impact and confidence; hospitalisation; infection and health economics. The results from this study will provide evidence of impact of SHC, barriers to patient and centre level adoption and inform development of future interventions to support its implementation. ISRCTN Number: 93999549 , (retrospectively registered 1st May 2017); NIHR Research Portfolio: 31566
机译:研究目标是评估结构化方案的有效性和经济影响,以支持患者参与中心的血液透析,并了解在什么情况下的工作原因以及为什么。它实现了一项共享血液透析护理程序(SHC),旨在改善那些用基于中心的血液透析治疗的人的经验和结果,并给予更多患者在中心和家中独立地透析透析的信心。 24个月混合方法队列600次普遍存在的高清患者的队列评估在30个月的质量改进计划内嵌套,旨在扩大英国12个透析中心的SHC。 SHC描述了一种干预,其中接受基于中心的血液透析的患者有机会学习,与其治疗相关的任务。在一个6个月的设置期间,使用随机阶梯式楔形设计,在12个透析装置上启动了分阶段的实施程序,其中6个中心参加了2个步骤,每个持续的6个月。干预利用质量改进方法涉及快速变化测试,以确定在学习协作的背景下实现最合适的实施机制。与阶梯式楔形干预并行运行是一种混合方法,队列评估员工调查问卷和访谈,并在研究期结束时与常规收集的数据联系起来。主要结果措施是使用3个月调查问卷进行收集的至少5个与透析相关任务的患者的数量。二次结果措施包括:在研究期结束时,选择在中心独立在中心进行家庭血液透析或透析的人数;最终用户推荐;家庭透析建立延迟;员工的影响和信心;住院;感染与健康经济学。本研究的结果将提供SHC,患者障碍的影响,患者和中心水平采用的影响,并告知发展未来干预措施,以支持其实施。 ISRCTN号码:93999549,(回顾性注册2017年5月1日); NIHR研究组合:31566

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号